The Thin Film Drug Manufacturing Market size is estimated to reach $16.7 billion by 2027, growing at a CAGR of 8.7% during the forecast period 2022-2027. The growth of the thin film drug manufacturing market is greatly fueled by the great market recognition and the growing demand for an efficient way of drug delivery. Thin film drugs have gained massive popularity in the market due to their easy application and great efficiency. Developed economies like the U.S. and nations in Europe have reported the momentous sale of thin film drugs. The growing demand for an efficient way of drug delivery and the limitations associated with the traditional forms of dosage are fueling the growth of the Thin Film Drug Manufacturing Market. The oral thin film may be utilized for the treatment of patients enduring schizophrenia and bipolar disorder. Providing oral film of the Anti-Migraine Drug to migraine patients with nausea, vomiting and sensitivity to light/sound has been analyzed to alleviate and ease their pain. Drug delivery firm Monosol Rx and partner Reckitt Benckiser Pharmaceuticals have accepted U.S. Food and Drug Administration (FDA) clearance to market a sublingual film formulation of the opioid dependence treatment - Suboxone. 

Thin Film Drug Manufacturing Market Growth Drivers:

The Efficiency of Thin Films in Drug Delivery:

As per World Health Organization (WHO), schizophrenia influences nearly 24 million people or 1 in 300 people (0.32%) globally. Treatment for schizophrenia performs best when commenced as early as possible. Thin film drug delivery utilizes a dissolving film or oral drug strip to direct medications through absorption in the mouth and/or through the small intestines. Thin film drug delivery has emerged as a progressive substitute to the conventional tablets, capsules and fluids that are frequently linked with prescription and OTC (over-the-counter) medicines. Thin films, as an emerging platform for drug delivery, are therefore driving the growth of the Thin Film Drug Manufacturing Industry. This further contributes to the Thin Film Drug Manufacturing Industry Outlook.

For More Queries About "Thin Film Drug Manufacturing Market" @

Great Benefits of Thin Films:

As per World Health Organization (WHO), half to three-quarters of adults aged 18–65 years across the world have had headaches in the last year. Among those individuals, 30% or more have recorded migraine. Several investigations have been performed where migraine patients were provided with the oral film of Anti-Migraine medication. Opioid-dependence medications are also available in the market. Opioid dependence treatment Suboxone has been granted U.S. FDA clearance. Thin films are a versatile platform that offers quick, regional or systemic impacts. Furthermore, these systems can be easily applied by themselves, specifically for dysphagia patients, geriatric, pediatric or bedridden patients, as well as patients who cannot access water easily. The numerous benefits of thin films are therefore propelling the growth of the Thin Film Drug Manufacturing Market. 


In December 2021, Amazon Web Services (AWS) declared that it was engaging with Pfizer to build creative, cloud-based solutions. The firms are investigating these advancements as a part of the Pfizer Amazon Collaboration Team (PACT) initiative.

Thin Film Drug Manufacturing Market: Competitive Landscape

Key companies holding major shares in the Thin Film Drug Manufacturing Market are Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., ZIM Laboratories Limited, Aquestive Therapeutics and Indivior PLC.

To request for a quote, provide your details in the below link:

Media Contact:
Mr. Venkat Reddy
Sales Manager
Contact Sales: +1-970-236-3677

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.